In Massachusetts, researchers found a way to help prevent fibrosis, or scar tissue from developing around medical implant devices. While biomaterial devices have been increasingly replacing metal ones in order to offer a more natural, less rejected type of material for patients’ bodies, biomaterial implants still face fibrosis issues which can impact how well the implant works. But researchers now can fight back against the scar tissue issue by blocking the molecule, CSF1, which signals to macrophages in the body to start building the scar tissue. Once blocked, the body doesn’t create the scar tissue, but interestingly, still allows the body to heal wounds and carry out other important functions. While they tested it on three different biomaterials, researchers believe it will work on any biomaterial and devices such as pacemakers and glucose sensors for diabetes patients.
Latest article
Fin-ished, for now: Aqua Cultured Foods shutters as funding dries up
In Chicago, a fermentation startup converting cellulose into seafood alternatives has wound down operations after failing to raise funds necessary to reach commercialization.
Established...
Mercedes unveils vegan-interior SUV at CES
In Nevada, Mercedes-Benz has showcased a new, vegan-interior GLC electronic SUV at the recent CES technology trade show in Las Vegas.
Vegan materials were...
Futerro files permits for French PLA site
In France, biobased chemicals maker Futerro has requested the relevant permits for its planned lactic acid and polylactic acid plant in France.
The plant, which...